CX3CL1 and neoplasm: Conversely, shRNA-mediated depletion of Cx3cl1 in SCT cells significantly reduced tumour growth in WT syngeneic immunocompetent mice (Fig. 4a, c), but not in immunodeficient mice (Fig. 4d).